Skip to search formSkip to main contentSkip to account menu

yttrium Y 90 monoclonal antibody HMFG1

Known as: Y 90 Monoclonal Antibody HMFG1, Y90 MOAB HMFG1, yttrium Y 90 MOAB HMFG1 
A radioimmunoconjugate of humanized monoclonal antibody (MoAb) HMFG1 labeled with Yttrium 90 (Y-90). MoAb MFG1 was raised against Human Milk Fat… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Introduction Most patients with oesophageal adenocarcinoma (OA) are unfit for curative treatment but are fit for photodynamic… 
2008
2008
Abstract MUC1, a type I transmembrane glycoprotein expressed on most epithelia and many cancer cells, is involved in embryo… 
2006
2006
The treatment course for advanced ovarian cancer is marked both by chemotherapy sensitivity at the outset and by eventual death… 
2004
2004
In this thesis, preclinical studies on new treatment modalities for ovarian cancer are descibed, applying radiolabeled antibodies… 
2002
2002
Extracorporeal immunoadsorption (ECAT) is a method of reducing activity in radiosensitive organs by removing excess monoclonal… 
2000
2000
We synthesized and characterized new chimera peptides by inserting an epitope of the mucin 1 glycoprotein (MUC1) as a 'guest… 
1995
1995
The pharmacokinetics, biodistribution, and dosimetry of an IgG1 radiolabeled anti-mucin mAb (HMFG1) and an isotype-matched… 
1990
1990
Spleen cells from inbred Biozzi mice, immunized against the human breast cancer cell line T47D, were fused with murine myeloma…